ANIX
Anixa Biosciences Inc (ANIX
NASDAQ · Healthcare · Biotechnology · US
$2.61
−2.25%11
Insider buys (3m)
0
Insider sells (3m)
$286.6K
Net value (3m)
-22.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 30, 2026 | Catelani Michael · officer: President, COO, & CFO | Purchase | 5,500 | $2.84 |
| Sep 28, 2026 | Baskies Arnold M · director | Purchase | 5,000 | $2.76 |
| Sep 28, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 7,000 | $2.78 |
| Sep 25, 2026 | Titterton Lewis H jr · director | Purchase | 49,036 | $2.69 |
| Sep 14, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 3,000 | $2.75 |
| Sep 14, 2026 | Titterton Lewis H jr · director | Purchase | 10,000 | $2.73 |
| Sep 11, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 5,000 | $2.76 |
| Aug 3, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 5,000 | $3.47 |
| Jul 29, 2026 | Baskies Arnold M · director | M-Exempt | 6,000 | $3.13 |
| Jul 29, 2026 | Baskies Arnold M · director | F-InKind | 5,428 | $3.46 |
| Jul 28, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 5,000 | $3.44 |
| Jul 27, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 3,188 | $3.37 |
| Jul 27, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 3,000 | $3.73 |
| Jul 21, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 5,000 | $3.46 |
| Jul 20, 2026 | Titterton Lewis H jr · director | Purchase | 12,000 | $3.47 |
| Jul 16, 2026 | Titterton Lewis H jr · director | Purchase | 2,797 | $3.28 |
| Jul 13, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 5,000 | $3.04 |
| Jun 17, 2026 | Titterton Lewis H jr · director | Purchase | 2,836 | $2.64 |
| Jun 16, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | Purchase | 21,000 | $2.50 |
| Jan 29, 2026 | Baskies Arnold M · director | Purchase | 10,000 | $3.04 |
| Jan 6, 2026 | KUMAR AMIT · director, officer: Chief Executive Officer | A-Award | 350,000 | $3.18 |
| Jan 6, 2026 | Titterton Lewis H jr · director | A-Award | 25,000 | $3.18 |
| Jan 6, 2026 | Baskies Arnold M · director | A-Award | 25,000 | $3.18 |
| Jan 6, 2026 | Catelani Michael · officer: President, COO & CFO | A-Award | 175,000 | $3.18 |
| Jan 6, 2026 | Gottschalk Emily · director | A-Award | 25,000 | $3.18 |
| Dec 16, 2025 | Titterton Lewis H jr · director | M-Exempt | 16,000 | $2.92 |
| Oct 31, 2025 | KUMAR AMIT · officer: Chief Executive Officer | F-InKind | 169,439 | $4.06 |
| Oct 31, 2025 | KUMAR AMIT · officer: Chief Executive Officer | M-Exempt | 200,000 | $2.92 |
| Aug 4, 2025 | Titterton Lewis H jr · director | Purchase | 10,000 | $3.08 |
| Jul 31, 2025 | KUMAR AMIT · officer: Chief Executive Officer | Purchase | 5,000 | $3.16 |
Institutional positioning
13F filings over the trailing two quarters
New 21Increased 30Reduced 22Sold out 11
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,329,852 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,314,982 | May 15, 2026 |
| UBS Group AG | Increased | 585,430 | Aug 13, 2026 |
| Laird Norton Wetherby Trust Company, LLC | Increased | 578,727 | Aug 14, 2026 |
| LAIRD NORTON TRUST COMPANY, LLC | Reduced | 566,327 | May 15, 2026 |
| UBS GROUP AG | Increased | 551,637 | May 5, 2026 |
| D.A. DAVIDSON & CO. | Unchanged | 539,272 | Jul 24, 2026 |
| D.A. DAVIDSON & CO. | Unchanged | 539,272 | May 5, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 364,731 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 359,194 | Aug 12, 2026 |
| MARSHALL WACE, LLP | Increased | 328,332 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 199,755 | Aug 7, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Increased | 192,356 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 191,074 | May 8, 2026 |
| MARSHALL WACE, LLP | Increased | 173,179 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 30, 2026